Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Organ Transplantation | 51 | 2024 | 1157 | 9.990 |
Why?
|
Kidney Transplantation | 134 | 2021 | 4234 | 7.540 |
Why?
|
Graft Rejection | 122 | 2024 | 4445 | 6.510 |
Why?
|
Graft Survival | 87 | 2022 | 3819 | 6.000 |
Why?
|
Tissue Donors | 63 | 2024 | 2331 | 5.710 |
Why?
|
Transplantation Immunology | 20 | 2018 | 532 | 3.780 |
Why?
|
Facial Transplantation | 17 | 2021 | 221 | 3.280 |
Why?
|
Reperfusion Injury | 25 | 2022 | 1023 | 3.270 |
Why?
|
Immunosuppressive Agents | 60 | 2020 | 4172 | 2.720 |
Why?
|
Brain Death | 19 | 2023 | 357 | 2.390 |
Why?
|
Aging | 28 | 2023 | 8705 | 2.320 |
Why?
|
Transplantation | 10 | 2024 | 219 | 2.260 |
Why?
|
Transplantation, Homologous | 76 | 2024 | 4808 | 2.120 |
Why?
|
Organ Preservation | 15 | 2023 | 382 | 2.010 |
Why?
|
Tissue and Organ Procurement | 16 | 2024 | 961 | 1.960 |
Why?
|
Uterus | 8 | 2022 | 649 | 1.950 |
Why?
|
Rats, Inbred Lew | 71 | 2023 | 1157 | 1.850 |
Why?
|
Immunity, Innate | 10 | 2020 | 3061 | 1.780 |
Why?
|
Skin Transplantation | 8 | 2024 | 1083 | 1.710 |
Why?
|
Rats, Inbred F344 | 58 | 2012 | 826 | 1.570 |
Why?
|
Heart Transplantation | 17 | 2021 | 3234 | 1.480 |
Why?
|
Transplantation Tolerance | 9 | 2021 | 605 | 1.470 |
Why?
|
Infertility, Female | 6 | 2022 | 760 | 1.390 |
Why?
|
Kidney | 47 | 2024 | 7049 | 1.360 |
Why?
|
Antilymphocyte Serum | 14 | 2020 | 487 | 1.360 |
Why?
|
Tissue and Organ Harvesting | 13 | 2021 | 373 | 1.360 |
Why?
|
Awards and Prizes | 3 | 2024 | 360 | 1.190 |
Why?
|
Adaptive Immunity | 5 | 2019 | 725 | 1.180 |
Why?
|
Liver Transplantation | 39 | 2021 | 2333 | 1.140 |
Why?
|
Tacrolimus | 25 | 2016 | 733 | 1.130 |
Why?
|
Facial Injuries | 4 | 2015 | 190 | 1.120 |
Why?
|
Cyclosporine | 25 | 2012 | 778 | 1.100 |
Why?
|
Immune System | 7 | 2021 | 795 | 1.080 |
Why?
|
Lymphocytes | 10 | 2020 | 2611 | 1.040 |
Why?
|
Living Donors | 14 | 2022 | 641 | 1.030 |
Why?
|
Heme Oxygenase (Decyclizing) | 8 | 2008 | 167 | 1.010 |
Why?
|
Tissue Transplantation | 3 | 2016 | 128 | 0.990 |
Why?
|
T-Lymphocytes | 28 | 2021 | 10194 | 0.980 |
Why?
|
Taurodeoxycholic Acid | 2 | 2021 | 13 | 0.980 |
Why?
|
Isoantibodies | 8 | 2020 | 674 | 0.970 |
Why?
|
Mice, Inbred DBA | 7 | 2021 | 621 | 0.960 |
Why?
|
Primary Graft Dysfunction | 2 | 2022 | 111 | 0.920 |
Why?
|
CD4-Positive T-Lymphocytes | 10 | 2021 | 4370 | 0.920 |
Why?
|
Animals | 142 | 2024 | 168441 | 0.920 |
Why?
|
Perfusion | 8 | 2023 | 1373 | 0.900 |
Why?
|
Kidney Failure, Chronic | 15 | 2020 | 2471 | 0.890 |
Why?
|
T-Lymphocytes, Regulatory | 7 | 2021 | 3077 | 0.880 |
Why?
|
Age Factors | 30 | 2021 | 18400 | 0.870 |
Why?
|
Rats | 83 | 2023 | 23742 | 0.870 |
Why?
|
NAD | 3 | 2018 | 614 | 0.860 |
Why?
|
Valine | 2 | 2021 | 408 | 0.840 |
Why?
|
Interferon-gamma | 12 | 2018 | 3159 | 0.790 |
Why?
|
Interleukin-10 | 3 | 2018 | 1175 | 0.790 |
Why?
|
Renal Insufficiency | 5 | 2013 | 809 | 0.780 |
Why?
|
Th17 Cells | 2 | 2020 | 794 | 0.780 |
Why?
|
Histocompatibility Testing | 8 | 2016 | 719 | 0.770 |
Why?
|
Mice, Inbred C57BL | 28 | 2024 | 22163 | 0.760 |
Why?
|
Bariatric Surgery | 2 | 2021 | 992 | 0.760 |
Why?
|
Inflammation | 15 | 2023 | 10762 | 0.720 |
Why?
|
Quercetin | 1 | 2020 | 97 | 0.690 |
Why?
|
Biomedical Research | 5 | 2020 | 3429 | 0.670 |
Why?
|
Societies, Medical | 7 | 2024 | 3905 | 0.670 |
Why?
|
Humans | 219 | 2024 | 761423 | 0.660 |
Why?
|
Death | 6 | 2023 | 676 | 0.660 |
Why?
|
Islets of Langerhans Transplantation | 1 | 2024 | 740 | 0.650 |
Why?
|
Immune Tolerance | 12 | 2023 | 2300 | 0.620 |
Why?
|
Dendritic Cells | 10 | 2024 | 2746 | 0.620 |
Why?
|
Cold Ischemia | 4 | 2018 | 70 | 0.620 |
Why?
|
Donor Selection | 5 | 2019 | 232 | 0.620 |
Why?
|
Islets of Langerhans | 1 | 2024 | 1346 | 0.590 |
Why?
|
Isoantigens | 9 | 2015 | 552 | 0.590 |
Why?
|
Renal Circulation | 2 | 2013 | 291 | 0.580 |
Why?
|
Nephrectomy | 10 | 2018 | 937 | 0.570 |
Why?
|
Hospitals, Special | 1 | 2017 | 91 | 0.560 |
Why?
|
Lymphocyte Activation | 10 | 2021 | 5490 | 0.550 |
Why?
|
Immunologic Memory | 4 | 2019 | 1358 | 0.540 |
Why?
|
Transplantation, Isogeneic | 13 | 2005 | 248 | 0.540 |
Why?
|
Gastrectomy | 1 | 2021 | 672 | 0.530 |
Why?
|
History, 20th Century | 7 | 2024 | 2769 | 0.510 |
Why?
|
Protoporphyrins | 7 | 2008 | 168 | 0.490 |
Why?
|
DNA, Mitochondrial | 1 | 2020 | 865 | 0.490 |
Why?
|
Urogenital Abnormalities | 1 | 2018 | 261 | 0.490 |
Why?
|
History, 21st Century | 5 | 2024 | 1567 | 0.470 |
Why?
|
Metabolome | 1 | 2021 | 987 | 0.460 |
Why?
|
Mice | 33 | 2024 | 81509 | 0.460 |
Why?
|
Periodicals as Topic | 2 | 2016 | 1463 | 0.460 |
Why?
|
Writing | 1 | 2016 | 199 | 0.450 |
Why?
|
Interleukin-17 | 3 | 2020 | 911 | 0.430 |
Why?
|
Warm Ischemia | 2 | 2012 | 58 | 0.430 |
Why?
|
Mice, Inbred BALB C | 9 | 2024 | 6215 | 0.430 |
Why?
|
Time Factors | 54 | 2018 | 39975 | 0.430 |
Why?
|
Fertility | 1 | 2018 | 771 | 0.430 |
Why?
|
Immunoconjugates | 2 | 2020 | 954 | 0.430 |
Why?
|
Bibliometrics | 1 | 2017 | 352 | 0.430 |
Why?
|
Kidney Tubules, Proximal | 2 | 2024 | 383 | 0.420 |
Why?
|
Fetus | 1 | 2020 | 1864 | 0.410 |
Why?
|
Pulsatile Flow | 2 | 2011 | 321 | 0.400 |
Why?
|
Humanism | 1 | 2013 | 86 | 0.400 |
Why?
|
Sirolimus | 3 | 2022 | 1533 | 0.400 |
Why?
|
Heme Oxygenase-1 | 9 | 2007 | 365 | 0.390 |
Why?
|
Organ Preservation Solutions | 4 | 2011 | 100 | 0.390 |
Why?
|
Kidney Diseases | 6 | 2017 | 2092 | 0.390 |
Why?
|
Postoperative Complications | 22 | 2020 | 15650 | 0.380 |
Why?
|
Exploratory Behavior | 1 | 2013 | 279 | 0.380 |
Why?
|
Upper Extremity | 1 | 2016 | 657 | 0.380 |
Why?
|
Male | 122 | 2024 | 360736 | 0.370 |
Why?
|
HLA Antigens | 7 | 2016 | 1371 | 0.370 |
Why?
|
Ischemia | 7 | 2020 | 1877 | 0.370 |
Why?
|
Burns, Electric | 1 | 2011 | 40 | 0.360 |
Why?
|
Cytokines | 22 | 2023 | 7392 | 0.360 |
Why?
|
Cryopreservation | 4 | 2010 | 728 | 0.360 |
Why?
|
Proteinuria | 17 | 2009 | 607 | 0.360 |
Why?
|
Naphthalenes | 1 | 2011 | 198 | 0.360 |
Why?
|
Hyperparathyroidism, Secondary | 1 | 2011 | 125 | 0.360 |
Why?
|
Frail Elderly | 1 | 2016 | 763 | 0.360 |
Why?
|
Obesity, Morbid | 1 | 2021 | 1277 | 0.360 |
Why?
|
Lung Transplantation | 4 | 2021 | 1309 | 0.360 |
Why?
|
Myelin Sheath | 1 | 2014 | 653 | 0.360 |
Why?
|
Blood Vessels | 1 | 2016 | 1113 | 0.350 |
Why?
|
Steroids | 2 | 2015 | 929 | 0.350 |
Why?
|
Skin Ulcer | 1 | 2011 | 130 | 0.350 |
Why?
|
Methylene Chloride | 2 | 2006 | 11 | 0.340 |
Why?
|
Editorial Policies | 1 | 2015 | 458 | 0.340 |
Why?
|
Tissue Survival | 2 | 2021 | 119 | 0.340 |
Why?
|
Obesity | 5 | 2023 | 12938 | 0.340 |
Why?
|
Treatment Outcome | 40 | 2021 | 64651 | 0.340 |
Why?
|
Plasmapheresis | 3 | 2014 | 206 | 0.330 |
Why?
|
Regional Blood Flow | 1 | 2013 | 1496 | 0.330 |
Why?
|
Calciphylaxis | 1 | 2011 | 130 | 0.330 |
Why?
|
Transplants | 2 | 2021 | 206 | 0.330 |
Why?
|
Parathyroidectomy | 1 | 2011 | 242 | 0.330 |
Why?
|
Renal Insufficiency, Chronic | 3 | 2024 | 2243 | 0.330 |
Why?
|
Cell Communication | 2 | 2016 | 1657 | 0.330 |
Why?
|
Cytotoxicity, Immunologic | 2 | 2014 | 1351 | 0.320 |
Why?
|
T-Lymphocyte Subsets | 2 | 2017 | 1806 | 0.320 |
Why?
|
Adoptive Transfer | 5 | 2016 | 819 | 0.320 |
Why?
|
Th1 Cells | 3 | 2019 | 1037 | 0.320 |
Why?
|
Reoperation | 17 | 2010 | 4303 | 0.320 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2014 | 822 | 0.320 |
Why?
|
Carbon Monoxide | 4 | 2007 | 546 | 0.310 |
Why?
|
Regeneration | 2 | 2014 | 1511 | 0.310 |
Why?
|
Forkhead Transcription Factors | 1 | 2016 | 1613 | 0.310 |
Why?
|
Wnt Proteins | 1 | 2012 | 718 | 0.310 |
Why?
|
Recombinant Fusion Proteins | 6 | 2013 | 3734 | 0.310 |
Why?
|
Flow Cytometry | 11 | 2018 | 5868 | 0.300 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2024 | 4575 | 0.300 |
Why?
|
Liver Failure | 2 | 2007 | 250 | 0.300 |
Why?
|
Antibodies, Monoclonal | 14 | 2017 | 9179 | 0.300 |
Why?
|
Quality Assurance, Health Care | 1 | 2018 | 2169 | 0.300 |
Why?
|
CD40 Ligand | 2 | 2022 | 523 | 0.300 |
Why?
|
Ischemic Preconditioning | 1 | 2008 | 89 | 0.290 |
Why?
|
Risk Factors | 31 | 2020 | 74167 | 0.290 |
Why?
|
Aged | 44 | 2023 | 169235 | 0.290 |
Why?
|
Desensitization, Immunologic | 2 | 2014 | 545 | 0.290 |
Why?
|
Mycophenolic Acid | 7 | 2015 | 348 | 0.280 |
Why?
|
Lymph Nodes | 6 | 2023 | 3466 | 0.280 |
Why?
|
Antibody Formation | 3 | 2008 | 1398 | 0.280 |
Why?
|
Inflammation Mediators | 2 | 2015 | 1886 | 0.270 |
Why?
|
Waiting Lists | 4 | 2021 | 765 | 0.270 |
Why?
|
Female | 82 | 2024 | 392581 | 0.260 |
Why?
|
Chronic Disease | 34 | 2017 | 9320 | 0.260 |
Why?
|
Informed Consent | 1 | 2012 | 1008 | 0.250 |
Why?
|
Gender Identity | 2 | 2023 | 766 | 0.250 |
Why?
|
Bone Marrow Transplantation | 1 | 2013 | 2695 | 0.250 |
Why?
|
Europe | 3 | 2024 | 3423 | 0.240 |
Why?
|
Face | 3 | 2019 | 1026 | 0.240 |
Why?
|
Cell Differentiation | 4 | 2020 | 11526 | 0.240 |
Why?
|
ABO Blood-Group System | 1 | 2007 | 380 | 0.240 |
Why?
|
Immunity | 2 | 2022 | 997 | 0.240 |
Why?
|
Carbon Monoxide Poisoning | 1 | 2005 | 65 | 0.230 |
Why?
|
Skin | 5 | 2024 | 4481 | 0.230 |
Why?
|
Middle Aged | 63 | 2020 | 220826 | 0.230 |
Why?
|
Adult | 62 | 2024 | 221148 | 0.230 |
Why?
|
Mycoses | 1 | 2007 | 386 | 0.230 |
Why?
|
Transplantation Conditioning | 3 | 2022 | 1590 | 0.230 |
Why?
|
Th2 Cells | 2 | 2019 | 1058 | 0.220 |
Why?
|
Patient Selection | 6 | 2020 | 4244 | 0.220 |
Why?
|
Models, Animal | 7 | 2017 | 2113 | 0.220 |
Why?
|
Surgical Procedures, Operative | 1 | 2015 | 1923 | 0.220 |
Why?
|
Burns | 1 | 2015 | 1882 | 0.210 |
Why?
|
Receptors, Antigen, T-Cell | 3 | 2021 | 2549 | 0.210 |
Why?
|
Antibodies | 5 | 2016 | 2421 | 0.210 |
Why?
|
Health Status | 1 | 2016 | 4075 | 0.210 |
Why?
|
Enzyme Induction | 5 | 2005 | 452 | 0.210 |
Why?
|
Raffinose | 1 | 2002 | 53 | 0.210 |
Why?
|
Kidney Function Tests | 5 | 2016 | 678 | 0.200 |
Why?
|
Cobalt | 1 | 2002 | 154 | 0.200 |
Why?
|
Antifungal Agents | 1 | 2007 | 752 | 0.200 |
Why?
|
Gene Expression Profiling | 6 | 2024 | 9418 | 0.200 |
Why?
|
Hindlimb | 1 | 2024 | 513 | 0.200 |
Why?
|
Methylprednisolone | 4 | 2009 | 384 | 0.190 |
Why?
|
Live Birth | 3 | 2022 | 511 | 0.190 |
Why?
|
Aging, Premature | 1 | 2021 | 44 | 0.190 |
Why?
|
Intercellular Adhesion Molecule-1 | 12 | 2010 | 1125 | 0.190 |
Why?
|
Receptors, Interleukin-2 | 5 | 2003 | 562 | 0.190 |
Why?
|
Allopurinol | 1 | 2002 | 198 | 0.180 |
Why?
|
Disease Models, Animal | 9 | 2021 | 18247 | 0.180 |
Why?
|
Injections, Intraperitoneal | 1 | 2021 | 413 | 0.180 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 3 | 2021 | 306 | 0.180 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5670 | 0.180 |
Why?
|
Mice, Obese | 1 | 2021 | 420 | 0.180 |
Why?
|
Complement System Proteins | 2 | 2014 | 788 | 0.180 |
Why?
|
Adrenocorticotropic Hormone | 2 | 2021 | 618 | 0.180 |
Why?
|
Receptors, Leptin | 1 | 2022 | 350 | 0.180 |
Why?
|
46, XX Disorders of Sex Development | 1 | 2020 | 34 | 0.180 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2023 | 267 | 0.170 |
Why?
|
Preoperative Care | 3 | 2010 | 2242 | 0.170 |
Why?
|
Interleukin-6 | 6 | 2018 | 3207 | 0.170 |
Why?
|
Gene Expression | 7 | 2018 | 7584 | 0.170 |
Why?
|
Cells, Cultured | 7 | 2017 | 18964 | 0.170 |
Why?
|
Glutathione | 1 | 2002 | 582 | 0.170 |
Why?
|
Ureteral Obstruction | 1 | 2021 | 293 | 0.170 |
Why?
|
Medication Adherence | 1 | 2011 | 2176 | 0.170 |
Why?
|
Risk Assessment | 10 | 2019 | 23990 | 0.170 |
Why?
|
Mullerian Ducts | 1 | 2020 | 203 | 0.170 |
Why?
|
Carrier Proteins | 1 | 2012 | 4936 | 0.170 |
Why?
|
Multiple Sclerosis | 1 | 2014 | 3224 | 0.170 |
Why?
|
Mice, Knockout | 6 | 2017 | 14409 | 0.160 |
Why?
|
Glucose Intolerance | 1 | 2023 | 575 | 0.160 |
Why?
|
Sex Characteristics | 4 | 2019 | 2637 | 0.160 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 9 | 2010 | 4575 | 0.160 |
Why?
|
End Stage Liver Disease | 1 | 2023 | 352 | 0.160 |
Why?
|
Liver | 7 | 2021 | 7532 | 0.160 |
Why?
|
Wounds and Injuries | 1 | 2011 | 2491 | 0.160 |
Why?
|
Hyperammonemia | 1 | 2019 | 76 | 0.160 |
Why?
|
Signal Transduction | 6 | 2022 | 23441 | 0.160 |
Why?
|
United States | 17 | 2022 | 72339 | 0.160 |
Why?
|
Hand-Assisted Laparoscopy | 1 | 2018 | 15 | 0.160 |
Why?
|
Follow-Up Studies | 30 | 2023 | 39117 | 0.150 |
Why?
|
Gift Giving | 1 | 2018 | 76 | 0.150 |
Why?
|
Epigenomics | 1 | 2024 | 942 | 0.150 |
Why?
|
Antigen Presentation | 2 | 2021 | 1253 | 0.150 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2023 | 974 | 0.150 |
Why?
|
Embryo Implantation | 1 | 2020 | 270 | 0.150 |
Why?
|
Primates | 1 | 2020 | 524 | 0.150 |
Why?
|
Survival Analysis | 13 | 2014 | 10089 | 0.150 |
Why?
|
Stem Cells | 2 | 2024 | 3522 | 0.150 |
Why?
|
Resource Allocation | 1 | 2020 | 350 | 0.150 |
Why?
|
Diffusion of Innovation | 2 | 2024 | 728 | 0.150 |
Why?
|
Interleukins | 4 | 2009 | 782 | 0.150 |
Why?
|
Retroperitoneal Space | 1 | 2018 | 170 | 0.150 |
Why?
|
Adenosine | 1 | 2002 | 808 | 0.140 |
Why?
|
Class Ib Phosphatidylinositol 3-Kinase | 1 | 2017 | 43 | 0.140 |
Why?
|
Myeloid Cells | 1 | 2022 | 823 | 0.140 |
Why?
|
Estradiol | 2 | 2021 | 1937 | 0.140 |
Why?
|
Lymphocyte Transfusion | 1 | 1998 | 232 | 0.140 |
Why?
|
Cytomegalovirus Infections | 3 | 2012 | 831 | 0.140 |
Why?
|
Histocompatibility | 2 | 2017 | 317 | 0.140 |
Why?
|
Cold Temperature | 3 | 2010 | 786 | 0.140 |
Why?
|
Altruism | 1 | 2018 | 208 | 0.140 |
Why?
|
Receptors, Natural Killer Cell | 1 | 2016 | 57 | 0.140 |
Why?
|
Gene Expression Regulation | 9 | 2021 | 11902 | 0.140 |
Why?
|
HLA-DR1 Antigen | 1 | 2016 | 12 | 0.130 |
Why?
|
Cell Movement | 6 | 2018 | 5203 | 0.130 |
Why?
|
Genes, T-Cell Receptor | 1 | 2016 | 30 | 0.130 |
Why?
|
Stromal Cells | 1 | 2022 | 1330 | 0.130 |
Why?
|
Interleukin-2 Receptor beta Subunit | 1 | 2016 | 25 | 0.130 |
Why?
|
Chemokine CCL3 | 1 | 2016 | 84 | 0.130 |
Why?
|
Thalidomide | 1 | 2021 | 885 | 0.130 |
Why?
|
Acute Disease | 11 | 2017 | 7238 | 0.130 |
Why?
|
International Cooperation | 3 | 2020 | 1422 | 0.130 |
Why?
|
Histocompatibility Antigens Class II | 6 | 2005 | 1444 | 0.130 |
Why?
|
Prednisolone | 6 | 2003 | 326 | 0.130 |
Why?
|
Pancreas | 1 | 2002 | 1690 | 0.130 |
Why?
|
Pregnancy | 5 | 2022 | 29862 | 0.130 |
Why?
|
Congenital Abnormalities | 1 | 2020 | 709 | 0.120 |
Why?
|
Congresses as Topic | 1 | 2020 | 803 | 0.120 |
Why?
|
Mice, Inbred CBA | 1 | 2016 | 436 | 0.120 |
Why?
|
Drug Delivery Systems | 2 | 2017 | 2225 | 0.120 |
Why?
|
Mice, Transgenic | 4 | 2018 | 9535 | 0.120 |
Why?
|
Antigens | 2 | 2016 | 1446 | 0.120 |
Why?
|
Monitoring, Immunologic | 1 | 2015 | 98 | 0.120 |
Why?
|
Hepatectomy | 4 | 2014 | 557 | 0.120 |
Why?
|
Hyperglycemia | 1 | 2023 | 1376 | 0.120 |
Why?
|
Ferrosoferric Oxide | 1 | 2016 | 348 | 0.120 |
Why?
|
Metabolomics | 1 | 2024 | 1657 | 0.120 |
Why?
|
Receptors, Interleukin-6 | 1 | 2016 | 225 | 0.120 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2018 | 481 | 0.120 |
Why?
|
Tryptophan Hydroxylase | 1 | 2014 | 94 | 0.120 |
Why?
|
Cell Adhesion Molecules | 8 | 1994 | 1600 | 0.120 |
Why?
|
Endothelium, Vascular | 3 | 2018 | 4430 | 0.120 |
Why?
|
Killer Cells, Natural | 3 | 2016 | 2203 | 0.120 |
Why?
|
Anastomosis, Surgical | 2 | 2010 | 982 | 0.120 |
Why?
|
Homeostasis | 2 | 2016 | 3321 | 0.110 |
Why?
|
Immunoglobulins | 3 | 2012 | 859 | 0.110 |
Why?
|
Blood Loss, Surgical | 1 | 2018 | 636 | 0.110 |
Why?
|
Graft vs Host Reaction | 1 | 2014 | 103 | 0.110 |
Why?
|
Amputees | 1 | 2014 | 91 | 0.110 |
Why?
|
Genes, Reporter | 1 | 2018 | 1529 | 0.110 |
Why?
|
Health Status Disparities | 2 | 2019 | 1852 | 0.110 |
Why?
|
Phenotype | 3 | 2019 | 16606 | 0.110 |
Why?
|
MicroRNAs | 4 | 2016 | 3812 | 0.110 |
Why?
|
Cell Adhesion | 3 | 2010 | 3087 | 0.110 |
Why?
|
Allergy and Immunology | 1 | 2015 | 176 | 0.110 |
Why?
|
Vascular Grafting | 1 | 2015 | 162 | 0.110 |
Why?
|
Capillaries | 1 | 2016 | 755 | 0.110 |
Why?
|
DNA | 2 | 2023 | 7219 | 0.110 |
Why?
|
Brazil | 1 | 2017 | 1230 | 0.110 |
Why?
|
Complement Activation | 2 | 2012 | 452 | 0.110 |
Why?
|
Surgical Wound Infection | 2 | 2012 | 1525 | 0.110 |
Why?
|
Mechanotransduction, Cellular | 1 | 2018 | 529 | 0.110 |
Why?
|
Healthcare Disparities | 3 | 2024 | 3357 | 0.100 |
Why?
|
Clinical Trials as Topic | 3 | 2019 | 8000 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3082 | 0.100 |
Why?
|
Polymers | 1 | 2020 | 1614 | 0.100 |
Why?
|
Consensus | 2 | 2020 | 3122 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3202 | 0.100 |
Why?
|
Informed Consent By Minors | 1 | 2012 | 9 | 0.100 |
Why?
|
Transplantation Chimera | 2 | 2013 | 594 | 0.100 |
Why?
|
Prognosis | 13 | 2019 | 29620 | 0.100 |
Why?
|
Glucocorticoids | 4 | 2011 | 2161 | 0.100 |
Why?
|
Delayed Graft Function | 2 | 2010 | 53 | 0.100 |
Why?
|
Hepatitis B | 4 | 2002 | 706 | 0.100 |
Why?
|
Tumor Necrosis Factor-alpha | 7 | 2020 | 4354 | 0.100 |
Why?
|
Anesthesia | 2 | 2014 | 1594 | 0.100 |
Why?
|
Rats, Inbred Strains | 3 | 2009 | 2089 | 0.100 |
Why?
|
Reactive Oxygen Species | 1 | 2020 | 2141 | 0.100 |
Why?
|
Access to Information | 1 | 2015 | 316 | 0.100 |
Why?
|
Enzyme-Linked Immunospot Assay | 1 | 2011 | 123 | 0.100 |
Why?
|
Vacuolar Proton-Translocating ATPases | 2 | 2006 | 195 | 0.100 |
Why?
|
Hemodynamics | 2 | 2012 | 4168 | 0.100 |
Why?
|
Immunohistochemistry | 12 | 2014 | 11073 | 0.100 |
Why?
|
Seasons | 1 | 2017 | 1519 | 0.100 |
Why?
|
Intestines | 1 | 2020 | 1909 | 0.090 |
Why?
|
Lymphocyte Depletion | 1 | 2013 | 602 | 0.090 |
Why?
|
Endocrine System | 1 | 2012 | 114 | 0.090 |
Why?
|
Laboratories | 1 | 2015 | 458 | 0.090 |
Why?
|
Carcinoma, Hepatocellular | 6 | 2020 | 2298 | 0.090 |
Why?
|
Antigens, CD | 7 | 2012 | 4001 | 0.090 |
Why?
|
Rats, Inbred BN | 2 | 2002 | 231 | 0.090 |
Why?
|
Insulin | 3 | 2002 | 6602 | 0.090 |
Why?
|
Registries | 4 | 2020 | 8223 | 0.090 |
Why?
|
Mast Cells | 1 | 2018 | 1391 | 0.090 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2019 | 2057 | 0.090 |
Why?
|
Patient Preference | 1 | 2018 | 924 | 0.090 |
Why?
|
Uremia | 1 | 2011 | 201 | 0.090 |
Why?
|
Immunocompetence | 1 | 2010 | 138 | 0.090 |
Why?
|
Proteasome Endopeptidase Complex | 2 | 2014 | 1320 | 0.090 |
Why?
|
Heat-Shock Proteins | 1 | 2014 | 796 | 0.090 |
Why?
|
Rosacea | 1 | 2011 | 59 | 0.090 |
Why?
|
Immunocompromised Host | 1 | 2015 | 856 | 0.090 |
Why?
|
Thigh | 1 | 2011 | 241 | 0.090 |
Why?
|
Liver Neoplasms | 7 | 2020 | 4320 | 0.090 |
Why?
|
Weight Loss | 1 | 2021 | 2683 | 0.090 |
Why?
|
Procaine | 1 | 2010 | 60 | 0.090 |
Why?
|
Blood Group Incompatibility | 1 | 2010 | 136 | 0.090 |
Why?
|
Phagocytosis | 1 | 2016 | 1536 | 0.090 |
Why?
|
Drug Therapy, Combination | 12 | 2005 | 6309 | 0.090 |
Why?
|
Lipids | 1 | 2021 | 3340 | 0.090 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2012 | 899 | 0.090 |
Why?
|
Lymphocele | 1 | 2009 | 18 | 0.090 |
Why?
|
Acute Kidney Injury | 2 | 2016 | 1924 | 0.080 |
Why?
|
Complement C3 | 2 | 2010 | 451 | 0.080 |
Why?
|
RNA, Messenger | 10 | 2010 | 12796 | 0.080 |
Why?
|
Cadaver | 3 | 2010 | 1358 | 0.080 |
Why?
|
Personal Autonomy | 1 | 2012 | 304 | 0.080 |
Why?
|
Potassium Chloride | 1 | 2010 | 230 | 0.080 |
Why?
|
Membrane Proteins | 4 | 2021 | 7856 | 0.080 |
Why?
|
Berlin | 1 | 2009 | 23 | 0.080 |
Why?
|
Mannitol | 1 | 2010 | 180 | 0.080 |
Why?
|
BK Virus | 1 | 2010 | 123 | 0.080 |
Why?
|
Ubiquitin | 1 | 2014 | 839 | 0.080 |
Why?
|
Neovascularization, Physiologic | 1 | 2016 | 1344 | 0.080 |
Why?
|
Forecasting | 1 | 2018 | 2928 | 0.080 |
Why?
|
Pancreas Transplantation | 1 | 2010 | 197 | 0.080 |
Why?
|
Isoflurane | 1 | 2012 | 384 | 0.080 |
Why?
|
Creatinine | 7 | 2016 | 1899 | 0.080 |
Why?
|
Lectins, C-Type | 1 | 2012 | 584 | 0.080 |
Why?
|
Multivariate Analysis | 3 | 2011 | 12058 | 0.080 |
Why?
|
Epithelial Cells | 3 | 2024 | 3667 | 0.080 |
Why?
|
Motivation | 1 | 2018 | 2006 | 0.080 |
Why?
|
Immunoglobulins, Intravenous | 2 | 2014 | 664 | 0.080 |
Why?
|
Geriatric Assessment | 1 | 2016 | 1409 | 0.080 |
Why?
|
Liver Cirrhosis | 5 | 2002 | 1934 | 0.080 |
Why?
|
Fluoroquinolones | 1 | 2010 | 307 | 0.080 |
Why?
|
Ureter | 1 | 2010 | 367 | 0.080 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2017 | 2863 | 0.080 |
Why?
|
Polyomavirus Infections | 1 | 2010 | 194 | 0.080 |
Why?
|
Stem Cell Transplantation | 1 | 2016 | 1600 | 0.070 |
Why?
|
Cadherins | 1 | 2012 | 904 | 0.070 |
Why?
|
Leadership | 1 | 2017 | 1385 | 0.070 |
Why?
|
Boronic Acids | 1 | 2012 | 915 | 0.070 |
Why?
|
Fibroblasts | 2 | 2022 | 4140 | 0.070 |
Why?
|
Retrospective Studies | 30 | 2021 | 80582 | 0.070 |
Why?
|
beta Catenin | 1 | 2012 | 1040 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 2 | 2008 | 1808 | 0.070 |
Why?
|
Protein Subunits | 2 | 2003 | 943 | 0.070 |
Why?
|
Ventilator Weaning | 1 | 2008 | 163 | 0.070 |
Why?
|
Necrosis | 1 | 2011 | 1608 | 0.070 |
Why?
|
Common Bile Duct | 1 | 2007 | 106 | 0.070 |
Why?
|
Predictive Value of Tests | 4 | 2015 | 15262 | 0.070 |
Why?
|
Erythrocyte Transfusion | 1 | 2011 | 565 | 0.070 |
Why?
|
Health Services Accessibility | 1 | 2024 | 5441 | 0.070 |
Why?
|
Antigens, Surface | 3 | 2016 | 1609 | 0.070 |
Why?
|
Immunologic Factors | 1 | 2016 | 1588 | 0.070 |
Why?
|
Residence Characteristics | 1 | 2017 | 2092 | 0.070 |
Why?
|
Receptors, Chemokine | 1 | 2010 | 652 | 0.070 |
Why?
|
Endothelium | 2 | 2022 | 765 | 0.070 |
Why?
|
Germany | 1 | 2009 | 875 | 0.070 |
Why?
|
Carboxyhemoglobin | 1 | 2006 | 83 | 0.070 |
Why?
|
Duodenal Diseases | 1 | 2007 | 100 | 0.070 |
Why?
|
Lung | 2 | 2022 | 9995 | 0.070 |
Why?
|
Lymphocyte Subsets | 2 | 1998 | 311 | 0.070 |
Why?
|
Contrast Media | 3 | 2016 | 5311 | 0.070 |
Why?
|
Muromegalovirus | 1 | 2006 | 31 | 0.070 |
Why?
|
Immunologic Techniques | 2 | 2003 | 213 | 0.070 |
Why?
|
Homeodomain Proteins | 1 | 2016 | 2416 | 0.070 |
Why?
|
Information Dissemination | 1 | 2015 | 1126 | 0.070 |
Why?
|
Autophagy | 1 | 2014 | 1326 | 0.070 |
Why?
|
Treatment Failure | 2 | 2002 | 2642 | 0.070 |
Why?
|
Ketamine | 1 | 2012 | 519 | 0.070 |
Why?
|
Cholangitis | 1 | 2007 | 111 | 0.070 |
Why?
|
Pyrazines | 1 | 2012 | 1201 | 0.070 |
Why?
|
Surgical Flaps | 1 | 2015 | 1671 | 0.070 |
Why?
|
Blood Coagulation | 1 | 2012 | 1154 | 0.060 |
Why?
|
Bacterial Infections | 3 | 2002 | 1393 | 0.060 |
Why?
|
Diverticulum | 1 | 2007 | 137 | 0.060 |
Why?
|
Azathioprine | 4 | 2000 | 354 | 0.060 |
Why?
|
Transforming Growth Factor beta | 3 | 2021 | 1960 | 0.060 |
Why?
|
Oligonucleotides, Antisense | 2 | 1998 | 461 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2010 | 3810 | 0.060 |
Why?
|
Bone Marrow Cells | 1 | 2013 | 2415 | 0.060 |
Why?
|
Boston | 3 | 2014 | 9330 | 0.060 |
Why?
|
Nanoparticles | 1 | 2017 | 1955 | 0.060 |
Why?
|
Health Care Costs | 1 | 2018 | 3243 | 0.060 |
Why?
|
Glomerular Filtration Rate | 5 | 2020 | 2176 | 0.060 |
Why?
|
Wound Healing | 1 | 2016 | 2803 | 0.060 |
Why?
|
Actins | 1 | 2012 | 2050 | 0.060 |
Why?
|
Toll-Like Receptors | 1 | 2008 | 589 | 0.060 |
Why?
|
Infusions, Intravenous | 1 | 2010 | 2218 | 0.060 |
Why?
|
Hemoperfusion | 1 | 2004 | 13 | 0.060 |
Why?
|
Young Adult | 7 | 2018 | 59207 | 0.060 |
Why?
|
Cohort Studies | 5 | 2018 | 41446 | 0.060 |
Why?
|
Pandemics | 5 | 2022 | 8641 | 0.060 |
Why?
|
Survival Rate | 13 | 2013 | 12720 | 0.060 |
Why?
|
Hyperbilirubinemia | 1 | 2004 | 74 | 0.060 |
Why?
|
Bilirubin | 2 | 2004 | 436 | 0.060 |
Why?
|
Macrophages | 8 | 2003 | 5768 | 0.060 |
Why?
|
Perception | 1 | 2010 | 1197 | 0.060 |
Why?
|
Angiography, Digital Subtraction | 1 | 2005 | 335 | 0.060 |
Why?
|
Bacterial Translocation | 1 | 2004 | 73 | 0.060 |
Why?
|
Antiviral Agents | 2 | 2010 | 3057 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2018 | 4014 | 0.060 |
Why?
|
Lymphocyte Count | 2 | 2003 | 778 | 0.060 |
Why?
|
Mice, Nude | 1 | 2010 | 3614 | 0.050 |
Why?
|
Minority Groups | 1 | 2010 | 1203 | 0.050 |
Why?
|
Drug Administration Schedule | 4 | 2005 | 4852 | 0.050 |
Why?
|
Hypertension, Renal | 1 | 2003 | 135 | 0.050 |
Why?
|
Caroli Disease | 1 | 2002 | 12 | 0.050 |
Why?
|
Interleukin-2 | 3 | 2008 | 1891 | 0.050 |
Why?
|
Recovery of Function | 1 | 2013 | 2977 | 0.050 |
Why?
|
Hepatitis, Autoimmune | 1 | 2005 | 172 | 0.050 |
Why?
|
Budd-Chiari Syndrome | 1 | 2002 | 24 | 0.050 |
Why?
|
Infant, Newborn | 2 | 2022 | 26212 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5335 | 0.050 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2012 | 2871 | 0.050 |
Why?
|
Renal Artery | 3 | 2016 | 351 | 0.050 |
Why?
|
Hepatitis, Viral, Human | 1 | 2002 | 141 | 0.050 |
Why?
|
2-Aminopurine | 1 | 2001 | 11 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2003 | 255 | 0.050 |
Why?
|
Hypotension | 1 | 2008 | 879 | 0.050 |
Why?
|
Simvastatin | 2 | 2018 | 346 | 0.050 |
Why?
|
Rats, Inbred WF | 3 | 1998 | 138 | 0.050 |
Why?
|
Goiter, Nodular | 1 | 2001 | 28 | 0.050 |
Why?
|
Synaptic Transmission | 1 | 2008 | 1173 | 0.050 |
Why?
|
Dendritic Cells, Follicular | 1 | 2022 | 50 | 0.050 |
Why?
|
Metabolic Diseases | 2 | 1999 | 681 | 0.050 |
Why?
|
Myoblasts | 1 | 2023 | 231 | 0.050 |
Why?
|
Dystrophin | 1 | 2023 | 283 | 0.050 |
Why?
|
Kruppel-Like Transcription Factors | 2 | 2018 | 502 | 0.050 |
Why?
|
Aged, 80 and over | 4 | 2017 | 58956 | 0.050 |
Why?
|
Patient Readmission | 1 | 2016 | 3269 | 0.050 |
Why?
|
Venules | 1 | 2022 | 161 | 0.050 |
Why?
|
Blood Pressure | 4 | 2012 | 8487 | 0.050 |
Why?
|
Ice | 1 | 2002 | 102 | 0.050 |
Why?
|
Child | 5 | 2021 | 80162 | 0.050 |
Why?
|
Freezing | 1 | 2002 | 310 | 0.050 |
Why?
|
Blood Transfusion | 1 | 2008 | 1299 | 0.050 |
Why?
|
Crystallization | 1 | 2002 | 533 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2014 | 4764 | 0.050 |
Why?
|
Comorbidity | 1 | 2015 | 10498 | 0.050 |
Why?
|
Membrane Glycoproteins | 2 | 2021 | 3702 | 0.050 |
Why?
|
Pituitary Hormones | 1 | 2002 | 182 | 0.050 |
Why?
|
Adolescent | 10 | 2014 | 88313 | 0.050 |
Why?
|
Kidney Tubules | 3 | 2010 | 449 | 0.050 |
Why?
|
Patient Acceptance of Health Care | 1 | 2014 | 3204 | 0.040 |
Why?
|
STAT5 Transcription Factor | 1 | 2021 | 264 | 0.040 |
Why?
|
Hyperthermia, Induced | 1 | 2004 | 417 | 0.040 |
Why?
|
Prednisone | 1 | 2005 | 1562 | 0.040 |
Why?
|
Enzyme Inhibitors | 2 | 2008 | 3712 | 0.040 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2003 | 584 | 0.040 |
Why?
|
Extracellular Matrix | 2 | 2022 | 1725 | 0.040 |
Why?
|
Interleukin-12 | 1 | 2003 | 583 | 0.040 |
Why?
|
Probiotics | 1 | 2004 | 377 | 0.040 |
Why?
|
Angiography | 1 | 2005 | 1599 | 0.040 |
Why?
|
Immunomodulation | 1 | 2024 | 548 | 0.040 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2003 | 649 | 0.040 |
Why?
|
Propionates | 1 | 2000 | 183 | 0.040 |
Why?
|
Liver Function Tests | 4 | 2005 | 523 | 0.040 |
Why?
|
Pancreatitis | 1 | 2007 | 1096 | 0.040 |
Why?
|
C-Peptide | 2 | 1999 | 440 | 0.040 |
Why?
|
Follicle Stimulating Hormone | 1 | 2002 | 726 | 0.040 |
Why?
|
Cholestasis, Extrahepatic | 1 | 1999 | 52 | 0.040 |
Why?
|
Hepatic Duct, Common | 1 | 1999 | 48 | 0.040 |
Why?
|
Radiographic Image Enhancement | 2 | 2016 | 876 | 0.040 |
Why?
|
Luteinizing Hormone | 1 | 2002 | 820 | 0.040 |
Why?
|
Animals, Newborn | 1 | 2005 | 2677 | 0.040 |
Why?
|
Proportional Hazards Models | 2 | 2011 | 12456 | 0.040 |
Why?
|
Belgium | 1 | 2019 | 118 | 0.040 |
Why?
|
Financing, Organized | 1 | 2020 | 204 | 0.040 |
Why?
|
Pituitary Gland | 1 | 2002 | 635 | 0.040 |
Why?
|
Cell Proliferation | 2 | 2016 | 10441 | 0.040 |
Why?
|
Common Bile Duct Neoplasms | 1 | 1999 | 120 | 0.040 |
Why?
|
Fibrosis | 3 | 2021 | 2048 | 0.040 |
Why?
|
Cognition | 1 | 2016 | 6986 | 0.040 |
Why?
|
Prevalence | 2 | 2013 | 15717 | 0.040 |
Why?
|
Muromonab-CD3 | 1 | 1998 | 104 | 0.040 |
Why?
|
Creatine | 1 | 2000 | 427 | 0.040 |
Why?
|
Major Histocompatibility Complex | 1 | 2001 | 927 | 0.040 |
Why?
|
Glucose | 1 | 2010 | 4347 | 0.040 |
Why?
|
Transplantation, Heterotopic | 1 | 2018 | 174 | 0.040 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2002 | 1171 | 0.040 |
Why?
|
Recurrence | 5 | 2017 | 8469 | 0.040 |
Why?
|
Crosses, Genetic | 1 | 1999 | 750 | 0.040 |
Why?
|
Sex Factors | 2 | 2023 | 10548 | 0.040 |
Why?
|
Lymphatic Vessels | 1 | 2022 | 358 | 0.040 |
Why?
|
DNA, Complementary | 3 | 2007 | 1992 | 0.040 |
Why?
|
Hormones | 1 | 2021 | 869 | 0.040 |
Why?
|
Listeriosis | 1 | 2018 | 149 | 0.030 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 2 | 1995 | 377 | 0.030 |
Why?
|
Transcription, Genetic | 3 | 2010 | 7595 | 0.030 |
Why?
|
Liver Failure, Acute | 1 | 1998 | 181 | 0.030 |
Why?
|
Incidence | 7 | 2020 | 21341 | 0.030 |
Why?
|
Body Mass Index | 2 | 2011 | 12951 | 0.030 |
Why?
|
Postoperative Period | 3 | 2008 | 1815 | 0.030 |
Why?
|
Listeria monocytogenes | 1 | 2018 | 249 | 0.030 |
Why?
|
Colon | 1 | 2004 | 1792 | 0.030 |
Why?
|
Thyroidectomy | 1 | 2001 | 907 | 0.030 |
Why?
|
Cell Line | 2 | 2022 | 15605 | 0.030 |
Why?
|
Virus Diseases | 1 | 2002 | 719 | 0.030 |
Why?
|
Sweden | 1 | 2019 | 1379 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2012 | 20556 | 0.030 |
Why?
|
Research Personnel | 1 | 2020 | 588 | 0.030 |
Why?
|
China | 1 | 2022 | 2366 | 0.030 |
Why?
|
Censuses | 1 | 2017 | 202 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 2 | 2002 | 1876 | 0.030 |
Why?
|
Biopsy | 3 | 2013 | 6766 | 0.030 |
Why?
|
Viral Proteins | 1 | 2003 | 1803 | 0.030 |
Why?
|
RNA, Small Interfering | 2 | 2018 | 3428 | 0.030 |
Why?
|
Health Care Rationing | 1 | 2018 | 437 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 5 | 2004 | 8179 | 0.030 |
Why?
|
Transplantation, Autologous | 2 | 2016 | 2116 | 0.030 |
Why?
|
Hysterectomy | 1 | 2020 | 857 | 0.030 |
Why?
|
Internationality | 1 | 2020 | 1001 | 0.030 |
Why?
|
DNA, Viral | 1 | 2001 | 2201 | 0.030 |
Why?
|
Blotting, Western | 3 | 2010 | 5036 | 0.030 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2019 | 497 | 0.030 |
Why?
|
Antigens, CD34 | 1 | 2016 | 658 | 0.030 |
Why?
|
Polyesters | 1 | 2016 | 373 | 0.030 |
Why?
|
Rabbits | 2 | 2011 | 4779 | 0.030 |
Why?
|
Chi-Square Distribution | 2 | 2011 | 3418 | 0.030 |
Why?
|
Occupational Health | 1 | 2020 | 806 | 0.030 |
Why?
|
Organ Size | 3 | 2012 | 2254 | 0.030 |
Why?
|
Blood Glucose | 2 | 1999 | 6391 | 0.030 |
Why?
|
Combined Modality Therapy | 3 | 2014 | 8529 | 0.030 |
Why?
|
Binding, Competitive | 1 | 1995 | 1141 | 0.030 |
Why?
|
Kidney Glomerulus | 4 | 1999 | 568 | 0.030 |
Why?
|
Antigens, CD20 | 1 | 2014 | 201 | 0.030 |
Why?
|
Mutation | 2 | 2017 | 30045 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2016 | 546 | 0.030 |
Why?
|
Jejunostomy | 2 | 2007 | 59 | 0.030 |
Why?
|
Bile Duct Neoplasms | 1 | 1999 | 605 | 0.030 |
Why?
|
Nephrons | 1 | 1994 | 168 | 0.030 |
Why?
|
Stomach Neoplasms | 1 | 2004 | 1459 | 0.030 |
Why?
|
Thermosensing | 1 | 2013 | 55 | 0.030 |
Why?
|
Vaccines | 1 | 2002 | 837 | 0.030 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2017 | 898 | 0.030 |
Why?
|
Interdisciplinary Communication | 1 | 2019 | 931 | 0.030 |
Why?
|
Hydrogen Peroxide | 1 | 2016 | 729 | 0.030 |
Why?
|
Carcinoma, Renal Cell | 1 | 2008 | 3163 | 0.030 |
Why?
|
Microspheres | 1 | 2016 | 785 | 0.030 |
Why?
|
Prospective Studies | 7 | 2021 | 54415 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2017 | 1612 | 0.030 |
Why?
|
Organizational Objectives | 1 | 2015 | 426 | 0.030 |
Why?
|
Receptors, Immunologic | 2 | 2016 | 1412 | 0.030 |
Why?
|
Stress, Mechanical | 1 | 2018 | 1674 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2016 | 1340 | 0.030 |
Why?
|
Models, Immunological | 1 | 1995 | 513 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 2 | 2014 | 2469 | 0.030 |
Why?
|
Radioisotope Renography | 1 | 2012 | 61 | 0.030 |
Why?
|
Carcinoma | 1 | 2004 | 2330 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2016 | 2016 | 0.030 |
Why?
|
Receptors, Progesterone | 1 | 1997 | 1129 | 0.030 |
Why?
|
High-Throughput Screening Assays | 1 | 2018 | 934 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 2 | 2014 | 6479 | 0.020 |
Why?
|
Exosomes | 1 | 2016 | 424 | 0.020 |
Why?
|
Graft Occlusion, Vascular | 1 | 1995 | 537 | 0.020 |
Why?
|
Receptors, CXCR4 | 1 | 2016 | 727 | 0.020 |
Why?
|
Quality of Life | 3 | 2021 | 13361 | 0.020 |
Why?
|
Hepatitis C, Chronic | 1 | 2020 | 1032 | 0.020 |
Why?
|
Immunoenzyme Techniques | 2 | 2010 | 1706 | 0.020 |
Why?
|
Chemotaxis, Leukocyte | 1 | 1994 | 663 | 0.020 |
Why?
|
Atrophy | 2 | 1994 | 1633 | 0.020 |
Why?
|
Length of Stay | 2 | 2018 | 6422 | 0.020 |
Why?
|
Pyrimidines | 2 | 2000 | 3027 | 0.020 |
Why?
|
Immunity, Cellular | 2 | 2014 | 1560 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2023 | 3576 | 0.020 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 694 | 0.020 |
Why?
|
Chemokine CCL19 | 1 | 2010 | 35 | 0.020 |
Why?
|
Touch | 1 | 2013 | 313 | 0.020 |
Why?
|
Chemokine CCL21 | 1 | 2010 | 50 | 0.020 |
Why?
|
Cause of Death | 1 | 2001 | 3684 | 0.020 |
Why?
|
Testosterone | 1 | 2002 | 2472 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2014 | 1847 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2018 | 2645 | 0.020 |
Why?
|
Cost of Illness | 1 | 2020 | 1936 | 0.020 |
Why?
|
Receptor, Endothelin A | 2 | 2000 | 56 | 0.020 |
Why?
|
Liver Diseases | 1 | 1999 | 1297 | 0.020 |
Why?
|
Receptors, Complement | 1 | 2010 | 253 | 0.020 |
Why?
|
Endothelins | 2 | 2000 | 127 | 0.020 |
Why?
|
Interleukin-15 | 1 | 2010 | 185 | 0.020 |
Why?
|
Umbilical Veins | 1 | 2010 | 426 | 0.020 |
Why?
|
Catheter-Related Infections | 1 | 2012 | 273 | 0.020 |
Why?
|
Neoplasms, Second Primary | 1 | 1997 | 1051 | 0.020 |
Why?
|
Protective Agents | 1 | 2010 | 150 | 0.020 |
Why?
|
Tissue Preservation | 1 | 2010 | 174 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2016 | 1843 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 1997 | 2208 | 0.020 |
Why?
|
Up-Regulation | 2 | 2010 | 4124 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 36423 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2011 | 942 | 0.020 |
Why?
|
Cytomegalovirus | 1 | 2012 | 756 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2019 | 2920 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2018 | 1943 | 0.020 |
Why?
|
Hypertension | 3 | 2004 | 8542 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2015 | 1504 | 0.020 |
Why?
|
Canada | 1 | 2013 | 2120 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2014 | 2426 | 0.020 |
Why?
|
Viremia | 1 | 2010 | 707 | 0.020 |
Why?
|
Anastomosis, Roux-en-Y | 1 | 2007 | 86 | 0.020 |
Why?
|
Kidney Diseases, Cystic | 1 | 2008 | 183 | 0.020 |
Why?
|
Analysis of Variance | 2 | 2011 | 6231 | 0.020 |
Why?
|
Lower Extremity | 1 | 2014 | 1201 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2018 | 5789 | 0.020 |
Why?
|
Serum Albumin | 1 | 2009 | 675 | 0.020 |
Why?
|
Chemokine CCL2 | 1 | 2008 | 605 | 0.020 |
Why?
|
Blood Urea Nitrogen | 1 | 2006 | 186 | 0.020 |
Why?
|
Observer Variation | 1 | 2012 | 2605 | 0.020 |
Why?
|
Communicable Diseases | 1 | 2014 | 875 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2016 | 5246 | 0.020 |
Why?
|
Renal Veins | 1 | 2005 | 102 | 0.020 |
Why?
|
Glucose Tolerance Test | 2 | 1999 | 1179 | 0.020 |
Why?
|
Anti-Infective Agents | 1 | 2012 | 982 | 0.020 |
Why?
|
Disease Progression | 2 | 2004 | 13502 | 0.020 |
Why?
|
Remission Induction | 1 | 2011 | 2395 | 0.020 |
Why?
|
Safety | 1 | 2010 | 1150 | 0.020 |
Why?
|
Cell Death | 1 | 2010 | 1677 | 0.020 |
Why?
|
Neoplasms | 4 | 2014 | 22164 | 0.010 |
Why?
|
Probability | 1 | 2010 | 2478 | 0.010 |
Why?
|
Adsorption | 1 | 2004 | 197 | 0.010 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2007 | 506 | 0.010 |
Why?
|
Peritoneal Lavage | 1 | 2004 | 30 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 2851 | 0.010 |
Why?
|
Aorta, Thoracic | 1 | 2010 | 1096 | 0.010 |
Why?
|
Administration, Oral | 2 | 2004 | 4016 | 0.010 |
Why?
|
Gene Silencing | 1 | 2010 | 1509 | 0.010 |
Why?
|
Desoxycorticosterone | 1 | 2003 | 46 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2016 | 4414 | 0.010 |
Why?
|
Colony Count, Microbial | 1 | 2004 | 330 | 0.010 |
Why?
|
Neutrophils | 2 | 1994 | 3766 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 1999 | 4021 | 0.010 |
Why?
|
Cecum | 1 | 2004 | 233 | 0.010 |
Why?
|
Immunoglobulin gamma-Chains | 1 | 2003 | 33 | 0.010 |
Why?
|
Ions | 1 | 2004 | 256 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2004 | 11740 | 0.010 |
Why?
|
Interleukin-12 Subunit p40 | 1 | 2003 | 57 | 0.010 |
Why?
|
Severity of Illness Index | 2 | 2016 | 15838 | 0.010 |
Why?
|
Aorta | 1 | 2010 | 2041 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2010 | 1667 | 0.010 |
Why?
|
Lactobacillus | 1 | 2004 | 212 | 0.010 |
Why?
|
Diabetic Nephropathies | 1 | 2010 | 973 | 0.010 |
Why?
|
Organoplatinum Compounds | 1 | 2004 | 407 | 0.010 |
Why?
|
Spleen | 2 | 2002 | 2295 | 0.010 |
Why?
|
Adenoviridae Infections | 1 | 2003 | 93 | 0.010 |
Why?
|
Liver Regeneration | 1 | 2004 | 213 | 0.010 |
Why?
|
Transfection | 1 | 2010 | 5775 | 0.010 |
Why?
|
Leucovorin | 1 | 2004 | 642 | 0.010 |
Why?
|
Pelvic Neoplasms | 1 | 2004 | 247 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2012 | 8999 | 0.010 |
Why?
|
Permeability | 1 | 2004 | 722 | 0.010 |
Why?
|
Atherosclerosis | 1 | 2018 | 3407 | 0.010 |
Why?
|
HLA-D Antigens | 1 | 2001 | 134 | 0.010 |
Why?
|
Organ Culture Techniques | 1 | 2004 | 794 | 0.010 |
Why?
|
Blood | 1 | 2004 | 598 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 6178 | 0.010 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2002 | 234 | 0.010 |
Why?
|
Pneumonia | 1 | 2012 | 2140 | 0.010 |
Why?
|
Viral Load | 1 | 2010 | 3330 | 0.010 |
Why?
|
Gastric Mucosa | 1 | 2004 | 604 | 0.010 |
Why?
|
Receptor, Endothelin B | 1 | 2000 | 46 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2006 | 1970 | 0.010 |
Why?
|
Hypocalcemia | 1 | 2001 | 201 | 0.010 |
Why?
|
Intubation, Intratracheal | 1 | 2008 | 1329 | 0.010 |
Why?
|
Lamivudine | 1 | 2001 | 366 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 26112 | 0.010 |
Why?
|
Myocardium | 1 | 2013 | 4725 | 0.010 |
Why?
|
Receptors, Endothelin | 1 | 1999 | 56 | 0.010 |
Why?
|
Heart | 1 | 2013 | 4405 | 0.010 |
Why?
|
Prolactin | 1 | 2002 | 625 | 0.010 |
Why?
|
Phenylpropionates | 1 | 1999 | 35 | 0.010 |
Why?
|
Genes, MHC Class II | 1 | 2000 | 451 | 0.010 |
Why?
|
GTPase-Activating Proteins | 1 | 2002 | 471 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2007 | 3779 | 0.010 |
Why?
|
Fluorouracil | 1 | 2004 | 1639 | 0.010 |
Why?
|
Disease-Free Survival | 2 | 2001 | 6814 | 0.010 |
Why?
|
Mitosis | 1 | 2004 | 1187 | 0.010 |
Why?
|
CD4-CD8 Ratio | 1 | 1998 | 114 | 0.010 |
Why?
|
Adenoviridae | 1 | 2003 | 1084 | 0.010 |
Why?
|
Vocal Cord Paralysis | 1 | 2001 | 272 | 0.010 |
Why?
|
Algorithms | 2 | 2013 | 14026 | 0.010 |
Why?
|
Lipopolysaccharides | 2 | 1996 | 2207 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2013 | 4946 | 0.010 |
Why?
|
Endothelin-1 | 1 | 1999 | 302 | 0.010 |
Why?
|
Actuarial Analysis | 1 | 1998 | 374 | 0.010 |
Why?
|
Lymphoma | 2 | 1997 | 1901 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2015 | 7389 | 0.010 |
Why?
|
Nervous System Diseases | 2 | 1998 | 1666 | 0.010 |
Why?
|
RNA | 1 | 2007 | 2723 | 0.010 |
Why?
|
Hepatocytes | 1 | 2004 | 1232 | 0.010 |
Why?
|
HLA-DR Antigens | 1 | 1998 | 631 | 0.010 |
Why?
|
Brain | 1 | 2023 | 27107 | 0.010 |
Why?
|
Molecular Weight | 1 | 1998 | 2188 | 0.010 |
Why?
|
Rectal Neoplasms | 1 | 2004 | 1157 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2004 | 9277 | 0.010 |
Why?
|
Computer Simulation | 2 | 1999 | 6238 | 0.010 |
Why?
|
Cross Infection | 1 | 2004 | 1421 | 0.010 |
Why?
|
Monocytes | 2 | 1994 | 2572 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2011 | 14599 | 0.010 |
Why?
|
Apoptosis | 1 | 2010 | 9488 | 0.010 |
Why?
|
DNA Primers | 1 | 1998 | 2820 | 0.010 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2002 | 1931 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2012 | 20093 | 0.010 |
Why?
|
Hydrocortisone | 1 | 2002 | 1815 | 0.010 |
Why?
|
Uterine Cervical Dysplasia | 1 | 1997 | 384 | 0.010 |
Why?
|
Menopause | 1 | 2002 | 1646 | 0.010 |
Why?
|
Bone Marrow | 1 | 2004 | 2910 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2003 | 3395 | 0.010 |
Why?
|
Genes, Immunoglobulin | 1 | 1994 | 285 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2004 | 4912 | 0.010 |
Why?
|
Postmenopause | 1 | 2002 | 2513 | 0.010 |
Why?
|
Hyperlipidemias | 1 | 1997 | 771 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2001 | 6086 | 0.010 |
Why?
|
Morbidity | 1 | 1997 | 1750 | 0.010 |
Why?
|
Extracellular Matrix Proteins | 1 | 1996 | 829 | 0.010 |
Why?
|
Bone Density | 1 | 2005 | 3551 | 0.010 |
Why?
|
Glomerulosclerosis, Focal Segmental | 1 | 1994 | 335 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2009 | 5840 | 0.010 |
Why?
|
CD4 Lymphocyte Count | 1 | 1997 | 2569 | 0.010 |
Why?
|
Triglycerides | 1 | 1998 | 2460 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2005 | 14664 | 0.010 |
Why?
|
Fibrin | 1 | 1993 | 507 | 0.010 |
Why?
|
Interleukin-1 | 1 | 1994 | 1249 | 0.010 |
Why?
|
Antigens, Differentiation | 1 | 1993 | 910 | 0.010 |
Why?
|
Cholesterol | 1 | 1998 | 2902 | 0.010 |
Why?
|
Integrins | 1 | 1993 | 834 | 0.000 |
Why?
|
Immunoglobulin M | 1 | 1993 | 1529 | 0.000 |
Why?
|
Base Sequence | 1 | 1998 | 12450 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1998 | 13449 | 0.000 |
Why?
|
Adenocarcinoma | 1 | 2004 | 6339 | 0.000 |
Why?
|
Hepatitis C | 1 | 1996 | 1584 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1998 | 17644 | 0.000 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2010 | 12143 | 0.000 |
Why?
|
Child, Preschool | 2 | 1999 | 42254 | 0.000 |
Why?
|
Leukocytes | 1 | 1993 | 2028 | 0.000 |
Why?
|
Uterine Cervical Neoplasms | 1 | 1997 | 2019 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1999 | 12970 | 0.000 |
Why?
|
Models, Biological | 1 | 1998 | 9469 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 2004 | 13637 | 0.000 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 1997 | 10203 | 0.000 |
Why?
|
Skin Neoplasms | 1 | 1997 | 5819 | 0.000 |
Why?
|